Medical startup Ferronova has raised $6 million in a top up of its five-year-old Series A to $17.5 million. The fresh funding was led by existing investors Uniseed/UniSuper, South Australian Venture Capital Fund, Artesian Venture Partners and Renew Pharmaceuticals, a subsidiary of Singapore- based Ultragreen.ai. The Adelaide biotech, founded in 2016 a spin-out from the… Read more »
Ahead of the TechStars Sydney ‘Demo the Future’ evening on December 8, Startup Daily is profiling the 12 startups and their founders in the 2025 cohort. Our next profile is OncoRevive – a health-tech startup which detects cancer early, leading to vastly improved patient outcomes. OncoRevive Founders: Dr. Mohammad Tavakkoli and Dr. Samira Sadeghi One-liner: Detect… Read more »
Kish Modi had a rule with friends and family once he was out of intensive care and began his treatment for leukaemia: no crying when they came to visit. His mum , a 157cm (5′ 2″) powerhouse, laid down the law to everyone who came to visit Kish in hospital. “She’s like, no tears, zero… Read more »
Consumer group CHOICE has tested 20 popular SPF 50 or 50+ sunscreens and found 16 of 20 products didn’t meet their SPF claims. The shocking results including prominent and trusted brands, including sunscreens from the Cancer Council, Coles, Woolworths and Aldi. One SPF 50+ brand’s result was so unbelievably poor that it was retested in… Read more »
Sydney clinical-stage radiopharmaceutical startup AdvanCell, which is developing innovative cancer therapeutics, has raised US$112 million (A$178m) in a Series C. The round was co-led by US-UK fund SV Health Investors, Sanofi Ventures, Abingworth, and SymBiosis. Additional support came from existing investor Morningside, alongside new investors Tenmile, Brandon Capital, and others. Founded in June 2019, AdvanCell was… Read more »
Melbourne biotech startup Cartherics has raised $15 million as it looks to begin trials of its cell therapy product for ovarian cancer. Cartherics, founded in 2015 by Alan Trounson, Bob Moses, and doctors Richard Boyd, Ian Nisbet and Peter Hudson, is developing immune cell therapies to treat cancer and other diseases. The startup previously raised $26… Read more »
A biotech startup focused on treating cancer has raised $5.4 million, led by mining billionaire Andrew Forrest’s Minderoo Foundation. Adelaide-based Carina Biotech will use the cash injection to develop its “CAR-T” cell therapies to treat cancers such as colorectal cancer, which is the deadliest cancer for 25-34-year-old Australians. Carina’s founding shareholders, board and management also… Read more »
If you’re reading this standing in a cafe queue, waiting for a latte on a work break, or guzzling your eighth espresso for the day while building your startup, we have an important announcement you need to read: Drinking coffee does not change your risk of being diagnosed with or dying from cancer. A… Read more »
After seeing a close friend’s battle with cancer, Jacqui Savage decided she had the background and skills to try to do something she hopes will save lives.
ooking to make the journey easier for patients of prostate cancer is Prostmate, a platform developed by Australian Prostate Cancer Research (APCR) and collaborators including Cancer Council Australia, St George Hospital, and Edith Cowan University.
RMIT University has signed an agreement with MGC Pharmaceuticals that will see them collaborate on medical cannabis research initiatives in Australia.
Sydney startup HealthMatch connects patients to registered clinical trials through an app backed by machine learning and a search algorithm.
Surgical Performance allows surgeons to input data around their surgeries and patient outcomes to track and benchmark their work.
Icon Group has announced a partnership with IBM Watson Health, that will see the AI used to help support clinical decision making for cancer patients.
EpiSoft is a Sydney-based startup working to develop cloud-based solutions for health professionals to manage patients with chronic diseases.
Daily startup news and insights, delivered to your inbox.
